“Study on DC-CTL Anti Viral Renal Cell Carcinoma Mediated By Adenovirus Vector Carrying Anti Immune Negative Regulation Gene and Carbonic Anhydrase IX Gene” applied by QiLu Cell Treaty Co., Ltd. was approved by Ji'nan Science and Technology Bureau’s “Enterprise independent innovation program” on October 17th and received funds 300 thousand Yuan of for science and technology.

“Enterprise independent innovation program” adheres to the big demand of national economic construction and social sustainable development, following municipal government's strategic deployment, taking promotion of the upgrading of industrial technology and structural adjustment and solving the major technical problems of social welfare as the main direction, to provide technical support for the adjustment of industrial structure, the cultivation of new industries, the sustainable development of society and the improvement of people's living quality by making breakthrough in key technologies, introduction of technology innovation, application and industrialization of high and new technology.

This project brings together the advanced science and technology and forms a high-level and high-quality research and development team, which becomes a strong guarantee for continuous progress and long-term development of the company's core technology.